Ocular symptoms and signs with preserved and preservative-free glaucoma medications

被引:306
|
作者
Jaenen, N.
Baudouin, C.
Pouliquen, P.
Manni, G.
Figueiredo, A.
Zeyen, T.
机构
[1] UZ Sint Rafael, Louvain, Belgium
[2] CNO XVXX, Paris, France
[3] Lab Thea, Clermont Ferrand, France
[4] Policlin Tor Vergata, Rome, Italy
[5] Hosp Santa Maria, Lisbon, Portugal
关键词
glaucoma; preserved and preservative free eyedrops; side effects;
D O I
10.1177/112067210701700311
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
PURPOSE. To compare the prevalence of side effects between eyedrops with or without preservatives, in terms of subjective symptoms and objective signs in patients with open-angle glaucoma. METHODS. In a multicenter cross-sectional epidemiologic survey in four European countries, ophthalmologists in private practice enrolled 9658 nonconsecutive patients using preservative (P) or preserva tive-free (PF) beta-blocking eyedrops between June 1997 and December 2003. Subjective symptoms, conjunctival and palpebral signs, and superficial punctate keratitis were explored before and after a change in therapy. For statistical analysis, a chi(2) test was used to calculate the differences in the prevalence of symptoms and signs with or without preservatives. RESULTS. A total of 74% of the patients used P, 12% PF, 10% a P-PF combination, and in 4% the type of medication was unknown. Each recorded symptom and all the palpebral, conjunctival, and corneal signs were significantly more frequent (p<0.0001) in the P-group than in the PF-group, such as pain or discomfort during instillation (48 vs 19%), foreign body sensation (42 vs 15%), stinging or burning (48 vs 20%), and dry eye sensation (35 vs 16%). A total of 68% of the patients had a second visit performed, of whom 63% (6083) had been evaluated on treatment difference. A significant decrease (p<0.0001) of all ocular symptoms and signs was observed in patients in whom the preserved eyedrops were diminished in number or altered into preservative free drops. CONCLUSIONS. Compared to preserved eyedrops, preservative free eyedrops are significantly less associated with ocular symptoms and signs of irritation.
引用
收藏
页码:341 / 349
页数:9
相关论文
共 50 条
  • [21] Efficacy and safety of preservative-free latanoprost eyedrops, compared with BAK-preserved latanoprost in patients with ocular hypertension or glaucoma
    Rouland, Jean-Francois
    Traverso, Carlo Enrico
    Stalmans, Ingeborg
    El Fekih, Lamia
    Delval, Laurent
    Renault, Didier
    Baudouin, Christophe
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2013, 97 (02) : 196 - 200
  • [22] Ocular surface assessment of preserved and preservative-free brimonidine tartrate in glaucoma patients: A parallel-grouped comparison trial
    Kim, Myungjin
    Rho, Seungsoo
    Lee, Chang Kyu
    Kim, Ko Eun
    Shin, Jonghoon
    Kim, Eunsol
    ACTA OPHTHALMOLOGICA, 2022, 100
  • [23] New Preservative-Free Formulation for the Enhanced Ocular Bioavailability of Prostaglandin Analogues in Glaucoma
    Alviset, Gabriel
    Corvis, Yohann
    Hammad, Karim
    Lemut, Josiane
    Maury, Marc
    Mignet, Nathalie
    Boudy, Vincent
    PHARMACEUTICS, 2022, 14 (02)
  • [24] Efficacy and safety levels of preserved and preservative-free tafluprost are equivalent in patients with glaucoma or ocular hypertension: results from a pharmacodynamics analysis
    Hamacher, Thomas
    Airaksinen, Juhani
    Saarela, Ville
    Liinamaa, M. Johanna
    Richter, Ulrich
    Ropo, Auli
    ACTA OPHTHALMOLOGICA, 2008, 86 : 14 - 19
  • [25] Comparative efficacy and safety of preserved versus preservative-free beta-blockers in patients with glaucoma or ocular hypertension: a systematic review
    Skov, Anne Guldhammer
    Rives, Amalie Santaolalla
    Freiberg, Josefine
    Virgili, Gianni
    Azuara-Blanco, Augusto
    Kolko, Miriam
    ACTA OPHTHALMOLOGICA, 2022, 100 (03) : 253 - 261
  • [26] Comparison of ocular surface assessment and adherence between preserved and preservative-free latanoprost in glaucoma: a parallel-grouped randomized trial
    Dai Woo Kim
    Jonghoon Shin
    Chang Kyu Lee
    Myungjin Kim
    Sohyeon Lee
    Seungsoo Rho
    Scientific Reports, 11
  • [27] Comparison of ocular surface assessment and adherence between preserved and preservative-free latanoprost in glaucoma: a parallel-grouped randomized trial
    Kim, Dai Woo
    Shin, Jonghoon
    Lee, Chang Kyu
    Kim, Myungjin
    Lee, Sohyeon
    Rho, Seungsoo
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [28] The RELIEF study: Tolerability and efficacy of preservative-free latanoprost in the treatment of glaucoma or ocular hypertension
    Misiuk-Hojlo, Marta
    Pomorska, Maria
    Mulak, Malgorzata
    Rekas, Marek
    Wierzbowska, Joanna
    Prost, Marek
    Wasyluk, Jaromir
    Lubinski, Wojciech
    Podboraczynska-Jodko, Karolina
    Romaniuk, Wanda
    Kinasz, Renata
    Ortyl-Markiewicz, Renata
    Mocko, Lucyna
    Zaleska-Zmijewska, Anna
    Rokicki, Dariusz
    Baudouin, Christophe
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2019, 29 (02) : 210 - 215
  • [29] Differential pharmacology and clinical utility of preservative-free tafluprost in the treatment of ocular hypertension and glaucoma
    Ermis, Sitki Samet
    CLINICAL OPHTHALMOLOGY, 2012, 6 : 673 - 678
  • [30] Efficacy and patient tolerability of preservative-free latanoprost compared with preservative prostaglandin analogs in patients with ocular hypertension or glaucoma
    El Ameen, A.
    Vandermeer, G.
    Pisella, P. J.
    ACTA OPHTHALMOLOGICA, 2016, 94